Orthostatic Hypotension News and Research

RSS
Nonmotor features may predict PD progression

Nonmotor features may predict PD progression

FDA approves RYTARY for Parkinson's disease treatment

FDA approves RYTARY for Parkinson's disease treatment

Many pediatric chest X-rays unnecessary, offer no clinical benefit

Many pediatric chest X-rays unnecessary, offer no clinical benefit

Nonmotor predictors of Parkinson’s dementia revealed

Nonmotor predictors of Parkinson’s dementia revealed

Study of astronauts show heart becomes more spherical when exposed to microgravity in space

Study of astronauts show heart becomes more spherical when exposed to microgravity in space

FDA grants accelerated approval to NORTHERA (droxidopa) for patients with symptomatic NOH

FDA grants accelerated approval to NORTHERA (droxidopa) for patients with symptomatic NOH

Sleep disorder linked to poor nonmotor status in Parkinson’s disease

Sleep disorder linked to poor nonmotor status in Parkinson’s disease

Study identifies possible link between orthostatic hypotension and atrial fibrillation

Study identifies possible link between orthostatic hypotension and atrial fibrillation

Study explores views, beliefs about triggers of Meniere's disease symptoms

Study explores views, beliefs about triggers of Meniere's disease symptoms

Study identifies why prazosin may cause lightheadedness and fainting

Study identifies why prazosin may cause lightheadedness and fainting

Nonmotor symptoms common in early-stage PD

Nonmotor symptoms common in early-stage PD

Dopaminergic treatment has ‘minor impact’ on autonomic symptoms in Parkinson’s

Dopaminergic treatment has ‘minor impact’ on autonomic symptoms in Parkinson’s

Renal denervation regenerates blood vessels and could reduce cardiovascular events

Renal denervation regenerates blood vessels and could reduce cardiovascular events

Five abstracts evaluating Abbott's LCIG presented at Parkinson's disease congress

Five abstracts evaluating Abbott's LCIG presented at Parkinson's disease congress

Abbott reports positive results from LCIG Phase 3 trial for advanced Parkinson's disease

Abbott reports positive results from LCIG Phase 3 trial for advanced Parkinson's disease

CDER, Shire enter agreement for ProAmatine clinical trial to treat symptomatic orthostatic hypotension

CDER, Shire enter agreement for ProAmatine clinical trial to treat symptomatic orthostatic hypotension

Shire announces update on approval status and availability of ProAmatine SOH drug

Shire announces update on approval status and availability of ProAmatine SOH drug

Chelsea uses PHT's LogPad, SitePad Tablet for clinical study to treat Parkinson's patients with NOH

Chelsea uses PHT's LogPad, SitePad Tablet for clinical study to treat Parkinson's patients with NOH

Chelsea reports top-line data from Phase III NORTHERA extension study in NOH

Chelsea reports top-line data from Phase III NORTHERA extension study in NOH

Combination therapy initially, best for blood pressure control: ACCELERATE study

Combination therapy initially, best for blood pressure control: ACCELERATE study